Full Text View
Tabular View
Study Results
Related Studies
A Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz
This study has been completed.
Study NCT01472380   Information provided by Mutual Pharmaceutical Company, Inc.

First Received on November 11, 2011.   Last Updated on July 30, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
efavirenz
fenofibric acid 105 mg
Additional drug interventions recognized in this trial
Fenofibrate
Fenofibric acid
More general drug interventions related to this trial
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Anticholesteremic Agents
Antimetabolites
Antiviral Agents
Enzyme Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Reverse Transcriptase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Mutual Pharmaceutical Company, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services